179 related articles for article (PubMed ID: 35546373)
1. Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502.
Mitani S; Kato K; Daiko H; Ito Y; Nozaki I; Kojima T; Yano M; Nakagawa S; Ueno M; Watanabe M; Tsunoda S; Abe T; Kadowaki S; Kadota T; Sasaki K; Machida R; Kitagawa Y
J Gastroenterol; 2022 Jul; 57(7):455-463. PubMed ID: 35546373
[TBL] [Abstract][Full Text] [Related]
2. High incidence of lung cancer death after curative endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
Tajiri A; Tsujii Y; Nishida T; Inoue T; Maekawa A; Kitamura S; Yamaguchi S; Nishihara A; Yamada T; Ogiyama H; Murayama Y; Yamamoto S; Egawa S; Uema R; Yoshihara T; Hayashi Y; Takehara T
Cancer Med; 2024 May; 13(9):e7242. PubMed ID: 38733176
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of esophageal squamous cell carcinomas and lugol-voiding lesions in patients with head and neck squamous cell carcinoma.
Fukuhara T; Hiyama T; Tanaka S; Oka S; Yoshihara M; Arihiro K; Chayama K
J Clin Gastroenterol; 2010 Feb; 44(2):e27-33. PubMed ID: 19730116
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristic of esophageal cancer without lugol-voiding lesions in the background esophagus.
Kuwabara H; Chiba H; Tachikawa J; Okada N; Ashikari K; Arimoto J; Nakaoka M; Sakai E; Goto T; Ohata K
Dig Endosc; 2020 May; 32(4):621-627. PubMed ID: 31965622
[TBL] [Abstract][Full Text] [Related]
5. Alcohol Consumption and Multiple Dysplastic Lesions Increase Risk of Squamous Cell Carcinoma in the Esophagus, Head, and Neck.
Katada C; Yokoyama T; Yano T; Kaneko K; Oda I; Shimizu Y; Doyama H; Koike T; Takizawa K; Hirao M; Okada H; Yoshii T; Konishi K; Yamanouchi T; Tsuda T; Omori T; Kobayashi N; Shimoda T; Ochiai A; Amanuma Y; Ohashi S; Matsuda T; Ishikawa H; Yokoyama A; Muto M
Gastroenterology; 2016 Nov; 151(5):860-869.e7. PubMed ID: 27492616
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.
Yen YC; Chang JH; Lin WC; Chiou JF; Chang YC; Chang CL; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
Cancer; 2017 Jun; 123(11):2043-2053. PubMed ID: 28152166
[TBL] [Abstract][Full Text] [Related]
7. Risk of superficial squamous cell carcinoma developing in the head and neck region in patients with esophageal squamous cell carcinoma.
Katada C; Muto M; Nakayama M; Tanabe S; Higuchi K; Sasaki T; Azuma M; Ishido K; Katada N; Yamashita K; Nemoto M; Shibata T; Masaki T; Okamoto M; Koizumi W
Laryngoscope; 2012 Jun; 122(6):1291-6. PubMed ID: 22674532
[TBL] [Abstract][Full Text] [Related]
8. Type of second primary malignancy after achieving complete response by definitive chemoradiation therapy in patients with esophageal squamous cell carcinoma.
Yamaguchi T; Kato K; Nagashima K; Iwasa S; Honma Y; Takashima A; Hamaguchi T; Ito Y; Itami J; Boku N; Higuchi K
Int J Clin Oncol; 2018 Aug; 23(4):652-658. PubMed ID: 29520523
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic findings corresponding to multiple Lugol-voiding lesions in the esophageal background mucosa.
Matsuno K; Ishihara R; Nakagawa K; Ohmori M; Iwagami H; Inoue S; Iwatsubo T; Nakahira H; Matsuura N; Shichijyo S; Maekawa A; Takashi K; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Matsunaga T
J Gastroenterol Hepatol; 2019 Feb; 34(2):390-396. PubMed ID: 30101499
[TBL] [Abstract][Full Text] [Related]
10. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer.
Muto M; Hironaka S; Nakane M; Boku N; Ohtsu A; Yoshida S
Gastrointest Endosc; 2002 Oct; 56(4):517-21. PubMed ID: 12297767
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with the presence of multiple Lugol-voiding lesions in patients with esophageal squamous-cell carcinoma.
Katada C; Muto M; Tanabe S; Higuchi K; Sasaki T; Azuma M; Ishido K; Katada N; Sakuramoto S; Yamashita K; Masaki T; Nakayama M; Okamoto M; Koizumi W
Dis Esophagus; 2014 Jul; 27(5):457-62. PubMed ID: 23009284
[TBL] [Abstract][Full Text] [Related]
12. Secondary esophageal squamous cell carcinoma after hematopoietic stem cell transplantation.
Nomura K; Iizuka T; Kaji D; Asano-Mori Y; Ochiai Y; Suzuki Y; Hayasaka J; Yamashita S; Matsui A; Kikuchi D; Taniguchi S; Takazawa Y; Hoteya S
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2137-2144. PubMed ID: 33387042
[TBL] [Abstract][Full Text] [Related]
13. Risk patterns of subsequent primary cancers following esophagectomy in early-stage thoracic esophageal squamous cell cancer patients.
Hu WS; Liu ZJ; Zhang JB; Wang ZL; Yang N; Xu L; Tian H; Zhang PL
Tumori; 2015; 101(3):328-33. PubMed ID: 25908032
[TBL] [Abstract][Full Text] [Related]
14. ADH1B and ALDH2 are associated with metachronous SCC after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
Kagemoto K; Urabe Y; Miwata T; Oka S; Ochi H; Kitadai Y; Tanaka S; Chayama K
Cancer Med; 2016 Jul; 5(7):1397-404. PubMed ID: 27038040
[TBL] [Abstract][Full Text] [Related]
15. Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus.
Matsubara T; Yamada K; Nakagawa A
J Clin Oncol; 2003 Dec; 21(23):4336-41. PubMed ID: 14645422
[TBL] [Abstract][Full Text] [Related]
16. Construction of a risk model for the development of metachronous squamous cell carcinoma after endoscopic resection of esopahageal squamous cell carcinoma.
Urabe Y; Kagemoto K; Nakamura K; Mizumoto T; Sanomura Y; Oka S; Ochi H; Tanaka S; Chayama K
Esophagus; 2019 Apr; 16(2):141-146. PubMed ID: 30173282
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma.
Suzuki Y; Kikuchi D; Hoteya S; Okamura T; Ochiai Y; Hayasaka J; Dan N; Mitsunaga Y; Tanaka M; Odagiri H; Nomura K; Yamashita S; Matsui A; Iizuka T
Digestion; 2021; 102(4):622-629. PubMed ID: 32992320
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors Linking Esophageal Squamous Cell Carcinoma With Head and Neck Cancer or Gastric Cancer.
Onochi K; Shiga H; Takahashi S; Watanabe N; Fukuda S; Ishioka M; Koizumi S; Matsuhasi T; Jin M; Iijima K
J Clin Gastroenterol; 2019 Apr; 53(4):e164-e170. PubMed ID: 29498952
[TBL] [Abstract][Full Text] [Related]
19. The Alcohol Use Disorders Identification Test and the risk of metachronous cancer after endoscopic resection of esophageal cancer.
Yokoyama A; Katada C; Yokoyama T; Takizawa K; Yano T; Oda I; Shimizu Y; Nakanishi H; Koike T; Hirao M; Okada H; Yoshii T; Katagiri A; Yamanouchi T; Matsuo Y; Kawakubo H; Kobayashi N; Ishikawa H; Muto M
Carcinogenesis; 2020 Aug; 41(8):1049-1056. PubMed ID: 32157279
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database.
Birkeland AC; Rosko AJ; Chinn SB; Prince ME; Sun GH; Spector ME
ORL J Otorhinolaryngol Relat Spec; 2016; 78(2):61-9. PubMed ID: 26910465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
